Comparison of RNA extraction kits and histological stains for laser capture microdissected prostate tissue

por Kolijn, Kimberley, van Leenders, Geert J. L. H.
Publicado 2016

Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer

por Kolijn, Kimberley, Verhoef, Esther I., van Leenders, Geert J.L.H.
Publicado 2015

On cribriform prostate cancer

por Kweldam, Charlotte F., van der Kwast, Theodorus, van Leenders, Geert J.
Publicado 2018

Prostate cancer growth patterns beyond the Gleason score: entering a new era of comprehensive tumour grading

por van Leenders, Geert J L H, Verhoef, Esther I, Hollemans, Eva
Publicado 2020

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review

por Hoogland, A. Marije, Kweldam, Charlotte F., van Leenders, Geert J. L. H.
Publicado 2014

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer

por Hoogland, A. Marije, Böttcher, René, Verhoef, Esther, Jenster, Guido, van Leenders, Geert J.L.H.
Publicado 2016

PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays

por de Jong, Joep J., Stoop, Hans, Boormans, Joost L., van Leenders, Geert J.L.H.
Publicado 2021

Non-prostatic pathology on prostate needle-biopsy – colorectal carcinoid: a case report

por van den Bergh, Roderick CN, Wolters, Tineke, Spaander, Manon CW, Schröder, Fritz H, van Leenders, Geert JLH
Publicado 2009

EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study

por Campos, Anna K., Hoving, Hilde D., Rosati, Stefano, van Leenders, Geert J. L. H., de Jong, Igle J.
Publicado 2016

Updating the Rotterdam Prostate Cancer Risk Calculator with Invasive Cribriform and/or Intraductal Carcinoma for Men with a Prior Negative Biopsy

por Remmers, Sebastiaan, Nieboer, Daan, Rijstenberg, L. Lucia, Hansum, Tim, van Leenders, Geert J.L.H., Roobol, Monique J.
Publicado 2021

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?

por Beukers, Willemien, Meijer, Titia, Vissers, Cornelis J., Boormans, Joost L., Zwarthoff, Ellen C., van Leenders, Geert J. L. H.
Publicado 2012

Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis

por Hollemans, Eva, Verhoef, Esther I., Bangma, Chris H., Rietbergen, John, Helleman, Jozien, Roobol, Monique J., van Leenders, Geert J.L.H.
Publicado 2018

Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy

por Hollemans, Eva, Verhoef, Esther I, Bangma, Chris H, Rietbergen, John, Roobol, Monique J, Helleman, Jozien, van Leenders, Geert J L H
Publicado 2020

Large and small cribriform architecture have similar adverse clinical outcome on prostate cancer biopsies

por Rijstenberg, L Lucia, Hansum, Tim, Kweldam, Charlotte F, Kümmerlin, Intan P, Remmers, Sebastiaan, Roobol, Monique J, van Leenders, Geert J L H
Publicado 2022

Concordance of cribriform architecture in matched prostate cancer biopsy and radical prostatectomy specimens

por Hollemans, Eva, Verhoef, Esther I, Bangma, Chris H, Schoots, Ivo, Rietbergen, John, Helleman, Jozien, Roobol, Monique J, van Leenders, Geert J L H
Publicado 2019

mTOR pathway activation is a favorable prognostic factor in human prostate adenocarcinoma

por Stelloo, Suzan, Sanders, Joyce, Nevedomskaya, Ekaterina, de Jong, Jeroen, Peters, Dennis, van Leenders, Geert J.L.H., Jenster, Guido, Bergman, Andries M., Zwart, Wilbert
Publicado 2016

Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic Review

por Khoraminia, Farbod, Fuster, Saul, Kanwal, Neel, Olislagers, Mitchell, Engan, Kjersti, van Leenders, Geert J. L. H., Stubbs, Andrew P., Akram, Farhan, Zuiverloon, Tahlita C. M.
Publicado 2023

Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer

por Böttcher, René, Hoogland, A. Marije, Dits, Natasja, Verhoef, Esther I., Kweldam, Charlotte, Waranecki, Piotr, Bangma, Chris H., van Leenders, Geert J.L.H., Jenster, Guido
Publicado 2015

Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies

por Osses, Daniël F., Arsov, Christian, Schimmöller, Lars, Schoots, Ivo G., van Leenders, Geert J.L.H., Esposito, Irene, Remmers, Sebastiaan, Albers, Peter, Roobol, Monique J.
Publicado 2020

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches

por Verhoeven, Marjolein, Ruigrok, Eline A. M., van Leenders, Geert J. L. H., van den Brink, Lilian, Balcioglu, Hayri E., van Weerden, Wytske M., Dalm, Simone U.
Publicado 2023